FindTrial
Sign In

Clinical study of hemophenin photodynamic therapy in the treatment of nevus flammeus

Clinical study of hemophenin photodynamic therapy in the treatment of nevus flammeus

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037153
Enrollment
Unknown
Registered
2020-08-27
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nevus flammeus

Interventions

Group 1:low poer density, 60mW/cm2
Group 2:medium power density, 80mW/cm2
Group 3:high power density, 100mW/cm2

Sponsors

Huashan Hospital affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: nevus flammeus on the face and neck, red or purplish red.

Exclusion criteria

Exclusion criteria: 1. Photosensitive patients, porphyria or porphyrin allergic; 2. Pregnant and lactating women; 3. Patients with serious cardiovascular diseases, abnormal liver and kidney function, abnormal coagulation function; 4. People with mental illness or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Efficacy;—

Countries

China

Contacts

Public ContactZhong Lu

Huashan Hospital affiliated to Fudan University

luzhong20100806@qq.com+86 13917682483

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026